All articles tagged with #insulin resistance
Google Research’s PhotoScan uses AI to analyze 2D selfies to estimate body fat and body-fat ratios (A/G and V/S) with high accuracy, building on data from DXA scans and MRI. The approach reportedly surpasses wearable bioelectrical impedance analyses and could even help predict insulin resistance, though Google hasn’t announced a consumer product and privacy concerns about sharing photos remain a hurdle.
GLP-1 obesity medications, including semaglutide, are showing early promise in treating PMOS by promoting weight loss, improving insulin resistance, and balancing hormones to support ovulation. Small studies led by Dr. Melanie Cree, including a Colorado patient who saw slowed hair growth, normalized periods, and significant weight loss, suggest potential benefits for PMOS patients. However, insurance coverage remains a major hurdle since PMOS is not an approved indication for these drugs and results vary, highlighting the need for more research and access solutions.
A University of Oulu study found higher daily coffee intake is associated with lower total body fat, more skeletal muscle, and less visceral fat, though causation is not proven. The analysis also noted lower levels of branched-chain amino acids and some gender-specific differences in glucose response, with no details on cup size or brewing methods.
HDL is the “good” cholesterol, but simply trying to raise it isn’t straightforward or reliably protective on its own. Experts say to focus on treating underlying health issues (like insulin resistance, obesity, and high blood pressure) and maintain core health habits—nutrient-rich diet, regular exercise, adequate sleep, and not smoking. HDL may rise as a byproduct of these changes, but some people are genetically predisposed to low HDL and still have cardiovascular risk. There are no proven foods or medications that dramatically raise HDL; optimizing LDL remains the primary strategy to lower heart disease risk.
Google unveiled the Pixel Watch 5 with Breathing Emergency Detection that uses on‑device AI and sensors to trigger emergency services if oxygen levels drop, though FDA clearance is pending and rollout is limited to select EU markets; the feature will also reach the Pixel Watch 4. Additionally, blood pressure and insulin resistance trends are coming to the Google Health app for Pixel Watch 3/4/5 and Fitbit devices this fall under a Health Guardian umbrella, offering monthly health reports and an AI Health Coach.
Google introduces Health Guardian for the Pixel Watch, an AI-powered suite that tracks monthly trends in blood pressure, breathing, and insulin resistance, with personalized tips and an emergency breathing alert system. Insulin-resistance monitoring aims to offer early metabolic insight, but the features are not diagnostic and regulatory clearance is pending. Availability varies by device: Blood Pressure and Insulin Trends arrive on Pixel Watch 3–5 and Fitbit Air this fall, while Breathing detection is live on Pixel Watch 4–5 (currently in several European countries) and not yet FDA-cleared.
Maryland-based physician Dr. Kunal Sood highlighted six signs of insulin resistance—increasing belly fat, darkened skin folds (acanthosis nigricans), fatigue after meals, cravings for carbs, skin tags, and increased thirst—explaining these symptoms reflect elevated insulin and signal risk for prediabetes and type 2 diabetes, underscoring the importance of early attention.
An increasing number of women with PCOS/PMOS are using off-label GLP-1 drugs like Ozempic to address insulin resistance and metabolic symptoms, with many reporting improved cycles and weight loss; some studies also show higher pregnancy rates when GLP-1s are added to metformin. Yet there is no FDA-approved PMOS indication, insurance coverage is inconsistent and costly, and long-term durability of benefit and optimal treatment duration remain under study; guidelines still emphasize lifestyle changes and metformin as first-line therapy, while patient experiences and online communities highlight a gap between care and what patients are seeking.
Insulin resistance often develops quietly before blood sugar rises and can lead to prediabetes, Type 2 diabetes, and other diseases. Doctors watch for signs like dark patches on the skin (acanthosis nigricans), skin tags, unexplained abdominal weight gain, and fatigue after meals. There’s no single gold-standard test; clues come from insulin and fasting glucose tests or rising A1C trends, and some patients use a continuous glucose monitor to gauge dietary impact. The condition is largely preventable and reversible with regular aerobic exercise, a high-fiber, low-glycemic diet, and weight management, though CGMs can create anxiety and should be discussed with a clinician.
Nutritionist Dr Rohini Patil explains belly fat isn’t just about overeating; refined carbs and sugary foods cause blood sugar swings that raise insulin and can drive insulin resistance and belly fat. Not eating enough protein or fiber, irregular eating, stress and sleep deprivation, and ultra-processed foods with trans fats and added sugars also fuel inflammation and insulin resistance. A sustainable approach—balanced meals with protein and fiber, regular meal times, exercise, adequate sleep, and stress management—improves insulin sensitivity and supports long‑term metabolic health.
A six‑week analysis cited in Annals of Internal Medicine shows that cutting about 80 minutes of sleep per night can cause roughly 0.45 kg (1 lb) weight gain, larger waistlines, and more sedentary behavior—even with a healthy diet and exercise. Dr. Sudhir Kumar emphasizes that sleep is a third pillar of weight management alongside diet and exercise, and most adults should aim for seven to nine hours of quality sleep nightly to protect metabolism, heart, and brain.
Sitting for most of the day—over eight to ten hours—can raise cardiovascular risk even if you exercise, by slowing metabolism, increasing blood sugar and insulin resistance, and promoting inflammation and arterial plaque. A 2025 JACC study found risk rises sharply after about 10.6 hours of daily sitting. Experts urge regular movement breaks—stand up, walk five minutes each hour, take stairs, stretch, and move during calls—because small bursts of activity benefit the heart, though they can’t fully offset long desk hours. If your day is desk-heavy, consult a cardiologist to assess your risk.
A 16-week mouse study found that removing sucrose from a low-fat diet disrupted gut bacteria, reduced beneficial microbes, and led to metabolic problems—impaired glucose control, insulin resistance, and fat buildup in the liver—despite similar body weight. The researchers caution that the findings, presented at ENDO 2026 and awaiting peer review, don’t yet translate to humans and suggest that completely eliminating sugar may not always be beneficial, underscoring the need to balance carbohydrates and gut health.
A mouse study presented at ENDO 2026 found that removing sucrose from a low-fat diet did not improve metabolic health but disrupted the gut microbiome, caused intestinal and liver inflammation, and worsened glucose tolerance and insulin resistance, despite similar weight to controls, suggesting that completely eliminating sugar may be counterproductive and that balanced carbohydrate intake supports gut and metabolic health.
A study presented at ENDO 2026 found that removing sucrose from a low-fat diet in mice worsened glucose control, increased inflammation, disrupted gut microbiota, and showed signs of fatty liver, suggesting that balanced carbohydrate intake supports gut and metabolic health rather than complete sugar elimination.